CME Group Inc. (NASDAQ:CME) Shares Sold by Northwestern Mutual Wealth Management Co.

Northwestern Mutual Wealth Management Co. cut its holdings in CME Group Inc. (NASDAQ:CME) by 2.7% during the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 12,600 shares of the financial services provider’s stock after selling 345 shares during the period. Northwestern Mutual Wealth Management Co.’s holdings in CME Group were worth $2,477,000 at the end of the most recent reporting period.

Several other hedge funds also recently added to or reduced their stakes in CME. B. Riley Wealth Advisors Inc. boosted its stake in CME Group by 1.3% during the fourth quarter. B. Riley Wealth Advisors Inc. now owns 3,625 shares of the financial services provider’s stock worth $782,000 after buying an additional 48 shares during the period. Capital Advisors Ltd. LLC increased its holdings in CME Group by 4.3% in the 1st quarter. Capital Advisors Ltd. LLC now owns 1,160 shares of the financial services provider’s stock valued at $250,000 after purchasing an additional 48 shares during the last quarter. Lantz Financial LLC raised its position in CME Group by 1.1% in the first quarter. Lantz Financial LLC now owns 4,561 shares of the financial services provider’s stock valued at $982,000 after purchasing an additional 49 shares during the period. Lester Murray Antman dba SimplyRich lifted its stake in CME Group by 0.7% during the second quarter. Lester Murray Antman dba SimplyRich now owns 7,667 shares of the financial services provider’s stock worth $1,507,000 after purchasing an additional 50 shares in the last quarter. Finally, Greystone Financial Group LLC boosted its position in shares of CME Group by 1.6% during the fourth quarter. Greystone Financial Group LLC now owns 3,282 shares of the financial services provider’s stock worth $691,000 after buying an additional 52 shares during the period. 87.75% of the stock is currently owned by hedge funds and other institutional investors.

CME Group Stock Up 0.1 %

Shares of NASDAQ CME opened at $224.43 on Friday. The business has a 50-day moving average of $212.17 and a two-hundred day moving average of $207.75. The company has a market capitalization of $80.81 billion, a price-to-earnings ratio of 25.53, a price-to-earnings-growth ratio of 8.74 and a beta of 0.55. CME Group Inc. has a 1 year low of $190.70 and a 1 year high of $226.78. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.02 and a quick ratio of 1.02.

CME Group (NASDAQ:CME) last announced its quarterly earnings results on Wednesday, July 24th. The financial services provider reported $2.56 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.53 by $0.03. CME Group had a return on equity of 12.82% and a net margin of 56.98%. The firm had revenue of $1.53 billion during the quarter, compared to the consensus estimate of $1.53 billion. During the same period in the prior year, the company posted $2.30 earnings per share. The firm’s quarterly revenue was up 12.7% compared to the same quarter last year. On average, analysts forecast that CME Group Inc. will post 9.94 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, September 25th. Investors of record on Monday, September 9th were paid a dividend of $1.15 per share. The ex-dividend date was Monday, September 9th. This represents a $4.60 annualized dividend and a yield of 2.05%. CME Group’s dividend payout ratio is currently 52.33%.

Insider Activity at CME Group

In other news, Director Bryan T. Durkin sold 7,593 shares of CME Group stock in a transaction dated Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the sale, the director now owns 55,607 shares in the company, valued at approximately $11,932,706.13. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In related news, CFO Lynne Fitzpatrick sold 754 shares of the stock in a transaction on Sunday, September 15th. The shares were sold at an average price of $216.99, for a total transaction of $163,610.46. Following the completion of the sale, the chief financial officer now owns 13,261 shares in the company, valued at $2,877,504.39. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Bryan T. Durkin sold 7,593 shares of CME Group stock in a transaction on Friday, August 30th. The shares were sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the completion of the transaction, the director now owns 55,607 shares in the company, valued at approximately $11,932,706.13. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.30% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on CME shares. Citigroup boosted their price objective on CME Group from $240.00 to $250.00 and gave the company a “buy” rating in a report on Thursday. Royal Bank of Canada reissued a “sector perform” rating and set a $235.00 price target on shares of CME Group in a research report on Thursday. Piper Sandler restated an “overweight” rating and issued a $225.00 price objective on shares of CME Group in a report on Tuesday, August 20th. Bank of America increased their target price on shares of CME Group from $177.00 to $180.00 and gave the stock an “underperform” rating in a report on Thursday. Finally, Barclays boosted their price target on shares of CME Group from $208.00 to $209.00 and gave the stock an “equal weight” rating in a research note on Thursday, July 25th. Four equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $213.77.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.